Direkt zum Inhalt
Merck

[Sequential liver transplantation: description of the first three patients in Spain].

Medicina clinica (2001-05-03)
J Figueras, M Munar-Qués, D Parés, J Torras, J Fabregat, A Rafecas, E Ramos, C Lama, E Jaurrieta
ZUSAMMENFASSUNG

Domino or sequential liver transplantation (DTXL) is a kind of living donor transplant, which was proposed in 1993 and performed for the first time in 1995; later on, more than 45 have been reported. The liver from a patient with familial amyloidotic polyneuropathy(FAP) is used to another patient aged more than 60 with hepatic disease generally cancer, because FAP livers are anatomically and functionally normal except for the synthesis of the systemic TTR variant which only could generate FAP in the recipient after more than 8 years. The three first cases of DTXL performed in Spain are presented. The donors were FAPTTRMet30 patients from the Major can focus. The first recipient showed severe hyperinsulinism due to metastatic liver from malignant insulinoma; the others had hepatocellular carcinoma on a cirrhotic liver. During the post operatory period liver function of recipients was perfect,and hyperinsulinism disappeared in the first; this patient died after 10 days by sepsis whereas the others showed normal liver function, no recurrent cancer nor onset of FAP. The donors outcome was normal with perfect liver function. Based on our results, in agreement with previous reports, we conclude that DTXH is valid procedure for a selected patient group. In addition they increase the pool of liver donors and therefore diminish the overloaded waiting lists.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Präalbumin aus Humanplasma, lyophilized powder